GlassScriptPhysician profile
Leslie B Vidal
NPI 1538251574
$60,425.56
in general payments reported to CMS, 2019-2025
8 companies · $7,229 in 2025
The $7,229 reported for 2025 was more than what 85% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $3,140 · 2021: $3,755 · 2022: $11K · 2023: $9,639 · 2024: $13K · 2025: $7,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,900 · Travel and Lodging: $2,925 · Food and Beverage: $1,096.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,192.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,900.00 |
| Travel and Lodging | $2,925.26 |
| Food and Beverage | $1,096.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $55,569.65 | 2019-2025 | Cap-Fix, Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Gemini Mountain Medical, LLC | $3,454.65 | 2019-2025 | |
| Arthrex, INC. | $942.00 | 2019 | |
| Stryker Corporation | $355.80 | 2024-2025 | Cinchlock, Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Horizon Therapeutics Plc | $29.89 | 2020-2021 | |
| Depuy Synthes Sales INC. | $26.52 | 2022 | |
| Pacira Therapeutics, INC. | $25.89 | 2019 | |
| Bioventus LLC | $21.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leslie Vidal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.